Solasia Pharma K.K. Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	45	41	48	49	58	109
Market Cap Growth	-14.88%	-14.77%	-0.90%	-16.70%	-46.47%	-3.19%
Enterprise Value	38	32	42	46	46	101
Last Close Price	0.14	0.13	0.19	0.27	0.34	0.81
PS Ratio	19.19	17.63	24.83	12.28	7.54	25.56
PB Ratio	4.70	4.32	6.79	4.04	3.09	5.52
P/TBV Ratio	4.70	4.32	6.79	10.00	7.54	28.12
EV/Sales Ratio	16.01	13.60	21.64	11.55	5.92	23.57
Debt / Equity Ratio	0.05	0.05	0.02	0.03	0.01	0.03
Net Debt / Equity Ratio	-0.74	-0.74	-0.74	-0.36	-0.29	-0.24
Net Debt / EBITDA Ratio	1.57	1.57	0.49	1.05	0.40	0.33
Net Debt / FCF Ratio	1.53	1.53	0.83	1.86	0.37	0.26
Asset Turnover	0.25	0.25	0.18	0.23	0.35	0.13
Inventory Turnover	1.84	1.84	1.05	4.12	-	-
Quick Ratio	5.64	5.64	5.79	2.71	3.38	1.72
Current Ratio	6.06	6.06	6.56	3.33	3.53	1.83
Return on Equity (ROE)	-60.25%	-60.25%	-128.08%	-49.02%	-97.08%	-79.44%
Return on Assets (ROA)	-30.62%	-30.62%	-67.88%	-26.55%	-49.20%	-33.90%
Return on Capital Employed (ROCE)	-46.90%	-46.90%	-166.80%	-58.80%	-90.60%	-91.10%
Earnings Yield	-10.64%	-11.58%	-24.74%	-14.67%	-30.96%	-17.35%
FCF Yield	-	-11.20%	-13.18%	-4.74%	-25.20%	-17.33%
Buyback Yield / Dilution	-19.53%	-19.53%	-18.18%	-10.62%	-16.78%	-10.88%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.